National Stock Number
6505-01-259-3891
National Stock Number (NSN) 6505-01-259-3891, or NIIN 012593891, (cephalexin capsules) was assigned July 17, 1987 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN replaces 2 stock numbers: 6505013719634, 6505013075422.
There are 11 manufacturer part numbers associated with this NSN. 4 of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 6 suppliers. Today, 5 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 3 suppliers are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of May 09, 2014. There have been 3 contracts issued for this part number, with 7 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE2DP13D0925, SPE2DP13D0925, SPE2DP13D0925, SPE2DP13D0925, SPM20005D0923. The total value of the awarded contracts has been US$ 902.16.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 02, 2006, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 31387. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505012593891 does not contain precious metals.
This NSN is associated to Schedule B 3004200060: medicaments containing other antibiotics, nesoi. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325412: pharmaceutical preparation manufacturing.
This information was last updated on Jul 01, 2025.